CoChat

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes

Open access

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Abstract

See Gordon and Tijms (doi:10.1093/brain/awz278) for a scientific commentary on this article. Jack et al. examine relationships between the bivariate distribution of β-amyloid and tau on PET and established neurocognitive clinical syndromes. Amyloidosis appears to be required for high levels of 3R/4R tau deposition. Whereas abnormal amyloid PET is compatible with normal cognition, highly abnormal tau PET is not.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awz268

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Amyloid and tau PET distributions by clinical group overall and within study. Scatter plots of tau PET SUVR versus amyloid PET SUVR among all individuals combined (A) and separately among individuals in the MCSA (B) and ADRC (C). Tau PET and amyloid PET values are in SUVR units but the data is plotted on log scale, which accounts for the uneven spacing. Points are coloured by clinical diagnosis. Histograms in the margins show the distributions of tau PET SUVR (right) and amyloid PET SUVR (top). Axis labels on the top represent amyloid PET values on a centiloid scale.
Figure 1 Amyloid and tau PET distributions by clinical group overall and within study. Scatter plots of tau PET SUVR versus amyloid PET SUVR among all individuals combined (A) and separately among individuals in the MCSA (B) and ADRC (C). Tau PET and amyloid PET values are in SUVR units but the data is plotted on log scale, which accounts for the uneven spacing. Points are coloured by clinical diagnosis. Histograms in the margins show the distributions of tau PET SUVR (right) and amyloid PET SUVR (top). Axis labels on the top represent amyloid PET values on a centiloid scale.CC BY-NC · PubMed Central
Figure 2 Amyloid and tau PET clusters. Scatterplot of tau PET SUVR versus amyloid PET SUVR with points coloured according to the three-cluster classification from a bivariate mixture model (A). Points shown in black represent individuals who were inconsistent with one of the three clusters. The vertical and horizontal lines represent the cut points of 1.48 SUVR for amyloid PET and 1.33 SUVR for tau PET. The ellipses show the centre 50% of the data for the three cluster distributions with a black star indicating the bivariate mean from the clustering. In B, these ellipses are shown along with a square for each clinical diagnosis group representing the bivariate median (centroid) of the tau and amyloid distributions. Tau PET and amyloid PET values are in SUVR units but the data is plotted on log scale, which accounts for the uneven spacing. Axis labels on the top represent amyloid PET values on a centiloid scale.
Figure 2 Amyloid and tau PET clusters. Scatterplot of tau PET SUVR versus amyloid PET SUVR with points coloured according to the three-cluster classification from a bivariate mixture model (A). Points shown in black represent individuals who were inconsistent with one of the three clusters. The vertical and horizontal lines represent the cut points of 1.48 SUVR for amyloid PET and 1.33 SUVR for tau PET. The ellipses show the centre 50% of the data for the three cluster distributions with a black star indicating the bivariate mean from the clustering. In B, these ellipses are shown along with a square for each clinical diagnosis group representing the bivariate median (centroid) of the tau and amyloid distributions. Tau PET and amyloid PET values are in SUVR units but the data is plotted on log scale, which accounts for the uneven spacing. Axis labels on the top represent amyloid PET values on a centiloid scale.CC BY-NC · PubMed Central
Figure 3 Amyloid and tau PET groups within clinical diagnosis. Per cent of individuals in each quadrant (A) or cluster (B) within each clinical diagnostic group. (A) Percentages according to amyloid and tau PET groupings based on the established cut points of 1.48 SUVR for amyloid PET and 1.33 SUVR for tau PET. (B) Percentages according to the bivariate mixture model clusters. These are labelled according to amyloid (low or high) and tau (low or high). Those individuals whose values were inconsistent with one of the three clusters were labelled as other.
Figure 3 Amyloid and tau PET groups within clinical diagnosis. Per cent of individuals in each quadrant (A) or cluster (B) within each clinical diagnostic group. (A) Percentages according to amyloid and tau PET groupings based on the established cut points of 1.48 SUVR for amyloid PET and 1.33 SUVR for tau PET. (B) Percentages according to the bivariate mixture model clusters. These are labelled according to amyloid (low or high) and tau (low or high). Those individuals whose values were inconsistent with one of the three clusters were labelled as other.CC BY-NC · PubMed Central
Figure 4 Scatter plots of tau PET SUVR versus amyloid PET SUVR by age groups among cognitively unimpaired (CU), MCI, and AlzCS individuals. MCSA individuals are shown in the left column and ADRC individuals in the right column. The vertical and horizontal lines represent the cut points of 1.48 SUVR for amyloid PET and 1.33 SUVR for tau PET. Points are coloured by clinical diagnosis. Tau PET and amyloid PET values are in SUVR units but the data is plotted on a log scale, which accounts for the uneven spacing. Axis labels on the top of the columns represent amyloid PET values on a centiloid scale.
Figure 4 Scatter plots of tau PET SUVR versus amyloid PET SUVR by age groups among cognitively unimpaired (CU), MCI, and AlzCS individuals. MCSA individuals are shown in the left column and ADRC individuals in the right column. The vertical and horizontal lines represent the cut points of 1.48 SUVR for amyloid PET and 1.33 SUVR for tau PET. Points are coloured by clinical diagnosis. Tau PET and amyloid PET values are in SUVR units but the data is plotted on a log scale, which accounts for the uneven spacing. Axis labels on the top of the columns represent amyloid PET values on a centiloid scale.CC BY-NC · PubMed Central
Figure 5 Scatter plots of tau PET SUVR versus amyloid PET SUVR among all individuals combined and separately among individuals in the MCSA and ADRC for three alternative tau PET regions of interest. Points are coloured by clinical diagnosis. Histograms in the margins show the distributions of tau PET SUVR (right) and amyloid PET SUVR (top). Axis labels on the top of each plot represent amyloid PET values on a centiloid scale. Tau PET and amyloid PET values are in SUVR units but the data is plotted on a log scale, which accounts for the uneven spacing.
Figure 5 Scatter plots of tau PET SUVR versus amyloid PET SUVR among all individuals combined and separately among individuals in the MCSA and ADRC for three alternative tau PET regions of interest. Points are coloured by clinical diagnosis. Histograms in the margins show the distributions of tau PET SUVR (right) and amyloid PET SUVR (top). Axis labels on the top of each plot represent amyloid PET values on a centiloid scale. Tau PET and amyloid PET values are in SUVR units but the data is plotted on a log scale, which accounts for the uneven spacing.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 93 references

Cited by

See all 206

Metadata

Authors
Jack, C. R., Wiste, H. J., Botha, H., Weigand, S. D., Therneau, T. M., Knopman, D. S., Graff-Radford, J., Jones, D. T., Ferman, T. J., Boeve, B. F., Kantarci, K., Lowe, V. J., Vemuri, P., Mielke, M. M., Fields, J. A., Machulda, M. M., Schwarz, C. G., Senjem, M. L., Gunter, J. L., & Petersen, R. C.
Affiliations
  • Mayo Clinic (US)
  • Department of Neurology, Mayo Clinic, Rochester, MN, USA
Corresponding author
Jack, Clifford R
Venue
Brain
Published
2019-09-09
Volume
142
Issue
10
Pages
3230-3242
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2972315303
Cited by
200
References
93
Citations by year
2026: 15 · 2025: 23 · 2024: 31 · 2023: 34 · 2022: 32 · 2021: 31 · 2020: 31 · 2019: 3
FWCI
19.32
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (R37 AG011378, RO1 AG041851, R01 AG056366, R01 NS097495, U01 AG06786, R01 AG034676, P50 AG016574)
  • GHR Foundation
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords
tau PET, amyloid-beta, bivariate distributions, mild cognitive impairment, frontotemporal dementia, dementia with Lewy bodies, Alzheimer's disease, tauopathy, amyloidosis, standardized uptake value ratio, cognitive aging, neurodegeneration biomarkers, Mayo Clinic Study of Aging, clinical syndromes
MeSH terms
Aged, Aged, 80 and over, Aging, Alzheimer Disease, Amyloid, Amyloidosis, Brain, Cognition, Female, Humans, Longitudinal Studies, Male, Middle Aged, Neuropsychological Tests, Biomarkers, Amyloid beta-Peptides, tau Proteins, Neurocognitive Disorders, Tauopathies, Positron-Emission Tomography, Frontotemporal Dementia, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes. https://app.cochat.ai/papers/10.1093/brain/awz268
The paper
Jack, C. R., Wiste, H. J., Botha, H., Weigand, S. D., Therneau, T. M., Knopman, D. S., Graff-Radford, J., Jones, D. T., Ferman, T. J., Boeve, B. F., Kantarci, K., Lowe, V. J., Vemuri, P., Mielke, M. M., Fields, J. A., Machulda, M. M., Schwarz, C. G., Senjem, M. L., Gunter, J. L., & Petersen, R. C. (2019). The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes. Brain. https://doi.org/10.1093/brain/awz268

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.